ROTOP – DMSA (ROTOP Pharmaka GmbH)
Welcome to the PulseAid listing for the ROTOP – DMSA drug offered from ROTOP Pharmaka GmbH. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ROTOP Pharmaka GmbH |
NON-PROPRIETARY NAME: | Kit for the Preparation of Technetium Tc99m Succimer Injection |
SUBSTANCE NAME: | 2,3-DIMERCAPTOSUCCINIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
START MARKETING DATE: | 2017-08-08 |
END MARKETING DATE: | 0000-00-00 |
ROTOP – DMSA HUMAN PRESCRIPTION DRUG Details:
Item Description | ROTOP – DMSA from ROTOP Pharmaka GmbH |
LABELER NAME: | ROTOP Pharmaka GmbH |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2017-08-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 71647-001_1af92f46-ef15-4b08-a75b-7206f752d1e4 |
PRODUCT NDC: | 71647-001 |
APPLICATION NUMBER: | |
Other 2,3-DIMERCAPTOSUCCINIC ACID Pharmaceutical Manufacturers / Labelers: